numbers-smoking associations were investigated in three scales: whole-genome, chromosome/arm and focal regions. We found that heavy cigarette smokers (>60 packyears) have significantly more copy number gains than non-/light smokers (≤60 packyears) (p=2.46×10 -4 ), especially in 8q and 12q. Copy number losses tend to occur away from genes in non-/light smokers (p=5.15×10 -5 ) but not in heavy smokers (p=0.52). Focal copy number analyses show that there are strong associations of copy number and cigarette smoking pack-years in 12q23 (p=9.69×10 -10 ) where IGF1 (insulin-like growth factor 1) is located. All of the above analyses were tested in the discovery set and confirmed in the validation set. DNA double-strand break assays using human bronchial epithelial cell lines treated with cigarette smoke condensate (CSC) were also performed, and indicated that CSC leads to genome instability in human bronchial epithelial cells.
We conclude that cigarette smoking leads to more copy number alterations, which may be mediated by the genome instability.
\body INTRODUCTION
Lung cancer, of which 85% is non-small cell lung carcinoma (NSCLC), is the second most common cancer and the leading cause of cancer-related death in the United States. (1) The epidemiologic evidence supporting that cigarette smoking is an important factor in causing lung cancer was reported almost six decades ago.(2-4) Moreover, lung cancer mortality mirrors trends in tobacco use (5) . Carcinogens derived from cigarette smoking damage lung epithelium by oxidative stress and direct DNA damage. (6) Although there has been progress in our understanding of lung carcinogenesis over the past few decades, the knowledge of mechanisms by which cigarette smoking causes lung cancer remains incomplete.
Profiles of copy number alterations (CNAs) in NSCLC have been studied. (7, 8) However, what causes copy number (CN) changes remain unknown. Several mechanisms of copy number changes have been proposed including homologous recombinations and non-homologous mechanisms.(9, 10) Bacteria, yeast and human seem to share similar mechanisms. (10) In bacteria, copy number alterations can be induced by environmental stress to enable swifter evolution in response to such stress. In the cell population within a tumor or precancerous lesion, similar stress such as hypoxia may induce copy number change. Thus, it is plausible to hypothesize that cigarette smoking serves as an environmental stress on the cells that leads to tumorigenesis by means of copy number alterations.
Using the tumor cells separated from malignant pleural effusions, it was found that gains of 11p were more frequent in smoking men than non-smoking men. (11) Furthermore, another study identified a copy number-based genomic signature in resected lung tumors for current smokers as compared to never smokers.(12) However, these studies had significant limitations. First, discrete smoking status (smokers vs. nonsmokers) may not be an optimal indicator to capture the dose-response relationship between cigarette smoking and copy number changes. Second, smoking may have different implications on copy number depending on whether it induces gains or losses.
Third, the conclusions in the previous studies were drawn based on modest sample sizes.
Lastly, none of previous studies provide a biological explanation on how cigarette smoking causes CNAs. To better investigate the relationship between cigarette smoking and copy number alterations, we conducted a genome-wide study of copy numbers and smoking pack-years in a large collection of resected NSCLC tumors. Our analyses cover the association of cigarette smoking with copy numbers on three different scales: wholegenome, chromosome/arm and focal copy numbers. The causal mechanism behind such smoking-CNAs association was further explored in a human non-tumorigenic bronchial cell line.
RESULTS
A total of 264 subjects were randomly divided into two data sets: discovery and validation sets. The characteristics of the populations are similar (Table 1) , indicating the balance of the two sets. Two alternative data splittings were pursued to prevent from the possibility that the results presented here are simply due to chance or to multiple comparisons. (SI Appendix (Tables S1-S3)) To account for batch effects, we also performed batch-adjusted analyses by normalization and explicitly adjusting for the batch identity as a covariate in the regression. The batch effect-adjusted analyses showed similar patterns to those without adjustment. (SI Appendix (Tables S4 and S5 ; Figure S1 ))
The analyses of smoking vs. copy number associations are outlined as three parts: on the genome-wide scale, on the chromosome/arm specific scale and on the focal region scale.
Cigarette smoking and whole-genome copy number pattern
There is a significant increase in total events of copy number gains among heavy smokers (>60 pack-years) (p=0.0080, 0.0095, and 2.5×10 -4 for discovery, validation and both sets, respectively), but no difference in copy number losses ( Figure 1A and 1B). No significant difference was observed in age, clinical stage, histology and gender between heavy and light/non-smokers.
For copy number losses, G/T ratios in light/non-smokers (≤60 pack-years) are significantly lower than the null ratio (i.e., the ratio when CNAs occur at random with respect to the gene location) (p=0.011, 9.80×10 -4 , and 5.15×10 -5 for discovery, validation and both sets, respectively) but heavy smokers (>60 pack-years) show no difference (p=0.78, 0.31 and 0.52, respectively) ( Figure 1C and 1D) . These results suggest that copy number losses tend to occur away from genes but such tendency disappears in heavy smokers. In contrast, there is no consistent pattern for copy number gains. Heavy smokers seem to have more genes with copy number changes, especially in gains. (SI Appendix Figure S4A )) The dose-response relationships between continuous copy numbers and smoking pack-years are also significant in 8q (p=0.015) and 12q (p=0.0025). (SI Appendix ( Figure S4B )) These two regions are also found the most signals in focal copy number analyses, as will be shown in the following.
Cigarette smoking and focal copy numbers
As stated in Materials and Methods, we performed single-and multiple-marker analyses to investigate the association of cigarette smoking and focal copy numbers. In the moving window 10-marker analyses, we selected the top 50 sets with smallest p values in the discovery set and tested the 50 sets using the validation set (p<0.05). Using such criteria, we identified one 10-marker set in 12q23 with p values of 9.69×10 -10 , which reached the genome-wide significance. ( Figure 3A That is, beyond a certain threshold, the higher smoking pack-years, the more departure from the neutral copy number. Notably, the threshold, about 60 pack-years, is consistent with the cut-off used in the above analyses of whole-genome CNAs pattern.
In addition to 12q23, 3q24 and 8q24 are two additional regions that are potentially associated with the pack-years of cigarette smoking from single-marker analyses. (SI Appendix (Figures S6 and S7)) We also performed the analyses in the dichotomous version, detail of which can be found in SI Appendix. (Table S7 and Figure S8 )
DNA double-strand break assay
To investigate further the results of our statistical analyses, we determined whether cigarette smoke could induce DNA double-stand breaks in cultured cells. To mimic longer and heavier cigarette smoking conditions, we treated human nontumorigenic bronchial epithelial cell HBEC 3KT with 0.04 and 0.4 μg/ml CSC for 24 hours. Under these conditions, the survival rates are 96.9% and 95.7%, respectively, indicating the dose of CSC and the length of treatment used in this study are not toxic to the cells ( Figure   4A ). To minimize background DNA double-strand breakage, we treated cells with CSC right after the growth had reached confluence. Under these conditions, ~5% of non-CSC treated cells still display double stand breaks ( Figure 4C ). When treated with 0.04 μg/ml CSC for 24 hours, the percentage of cells with double strand breaks increased to 15%.
This percentage doubled with the application of more concentrated 0.4 μg/ml CSC ( Figure 4C ). We also treated the cells with 0.4 μg/ml CSC for 2 hours, and observed a similar DNA double-strand break ratio as that of the non-CSC treated control cells, suggesting DNA double-strand break occurring after a longer time of CSC treatment.
To determine the effects of CSC on induction of cellular apoptosis which indirectly contributes to DNA double-strand breaks, the same set of cells (as used in Figure 4B and 4C) were lysed for apoptotic-specific Caspase-3/7 activity. As shown in Figure 4D , there is a basal level of Caspase-3/7 activity in non-CSC treatment cells. Upon CSC treatment, the value of relative fluorescence unit (RFU) increased in a dosedependent matter. However, the extent to which the RFU value increased in response to CSC treatment was much less than the corresponding increase in DNA double strand breaks in Figure 4C . Collectively, these results indicate that higher CSC leads to genome instability in bronchial epithelial cells. As such, theses data provide biological evidence to bridge the associations between CNAs and smoking observed in the above human data.
DISCUSSION
We show that heavy smokers (>60 pack-years) have more copy number gains than light/non-smokers but not copy number losses and that light/non-smokers (≤60 packyears) have copy number losses away from the gene location, in contrast to heavy smokers. The discrepancy between gains and losses suggests that different mechanisms may exist for the genome impact of cigarette smoking. For gains, smoking executes its oncogenic effect by increasing the event of copy number changes. For losses, in contrast, smoking does not increase CNAs events but increase the proportion of genes being affected. Because losing a fragment of DNA is less favorable than gaining one (13) , two separate mechanisms may be developed to hit the genes responsible for tumorigenesis.
The phenomenon may be a consequence of selection during cancer development and cell proliferation. Because different cells possess different CNAs, selection by a nutrientlimited environment makes those clones that can grow without regulatory control become dominant.
For heavy smokers, there were more copy number gains compared to non-or light smokers and no tendency for copy number losses to occur away from the gene location.
We have also found that genes with gains are more likely to be oncogenes or to be involved in pathways that are associated with tumor growth, which suggests that lung cancer cells in heavy smokers tend to acquire the growth advantage via copy number gains. (14) As a result, copy number losses within genes have less unfavorable impact on such cells since it is compensated by the fact that they can grow without regulation. This explains our observation that the proportion of losses within gene among heavy smokers is not different from that at random.
Previous studies have shown that copy number alterations are more frequent in smokers than in non-smokers, (11, 12 ) consistent with our findings based on pack-years.
Copy number-based genomic signature has also been identified to discriminate current smokers and never smokers (12) , which, however, does not include IGF1. Smoking status may not necessarily reflect the same oncogenic feature as pack-years of smoking, a measure of cumulative exposure. Furthermore, the large sample size and discoveryvalidation process in this study increase robustness of the findings. Several studies have provided the links among smoking, IGF1 and cancer. For example, it has been reported that smoking may affect IGF1 serum level and its signaling. (18, 19) On the other hand, IGF1 and the risk of developing cancer have also been extensively studied in lung cancer (20) (21) (22) (23) , breast cancer(24), prostate cancer (25) and colorectal cancer (26) . Our analysis supports the hypothesis that smoking can act through increasing the copy number of IGF1 to induce its over-expression and subsequent oncogenesis. 
MATERIALS AND METHODS

Study
DNA quality, histopathology and genechip
DNA was extracted from tumor and non-neoplastic lung parenchyma after manual microdissection from 5-μm thick histopathologic sections. Each specimen was evaluated for amount and quality of tumor cells. Tumors were reviewed and classified using the WHO criteria. Specimens with lower than 70% tumor cellularity, inadequate DNA concentration, or not intact genomic DNA were not included for chip hybridization. The platform of genechip is Affymetrix 250K Nsp GeneChip®.
Data preprocessing
Copy numbers were obtained with dChip software by invariant set normalization and median smoothing with the window of 11 loci. (29) Only 256,554 probes on somatic chromosomes were analyzed. We further classified the continuous inferred copy number into a discrete variable of CNAs: copy number gains defined as copy numbers ≥2.7 and copy number losses defined as copy numbers ≤1.3, to detect copy number ≥3 and ≤1 by tolerating 30% normal tissue contamination. The probes were mapped to the RefSeq genes with 2 kb extension both upstream and downstream using the UCSC Genome Browser. Among the 256,554 probes on somatic chromosomes, 104,256 (40.64%) were mapped to 11,700 genes.
Statistical analysis
Only early stage tumors were analyzed here because we have found that late stage tumors have more CNAs. The number of pack-years is defined as the packs of cigarette smoked per day multiplied by the years of smoking. 60 pack-years of cigarette smoking was chosen as the cut-off for heavy and light/non-smokers according to the observation of total CNAs events by the interval of 10 pack-years in both discovery and validation sets (SI Appendix (Figure S9) ). Using the cut-off, we had 203 light/non-smokers and 61 heavy smokers. We developed three methods to test the genome-wide or chromosome/arm-specific copy number patterns between heavy and light/non-smokers and one method to test the association of the chromosome/arm-specific or focal CNs and smoking pack-years.
First, we calculated the total events of copy number gains and losses and compared them between the two smoking groups by the two-sided t test, which provides a convenient summary index but collapses CNAs information over the genomic locations.
The second method is to apply two-sample tests for continuous copy number by calculating the standardized difference of two average copy numbers for each locus as:
where m ji and v ji is the estimated mean and variance, respectively, of copy number for group j at locus i, and n j is the sample size in group j.
We summed up c i 2 over i across the loci in the arm of a chromosome to calculate the observed total standardized squared difference (C observed ). By permuting the two groups and carrying out the above procedure for 10,000 times, we obtained a non-parametric null 
f is the F statistics of regressing continuous copy numbers on the smoking pack-years (square-root transformed) up to the quadratic term at locus i. Again, the non-parametric null distribution (F null ) was generated by 10,000 permutations and p values were obtained as the tail probability of F observed in F null .
The proposed test is equivalent to the powerful score test for testing the variance of coefficients in a multivariate regression by assuming regression coefficients have an arbitrary distribution with mean 0 and variance τ (30), in which copy numbers of a region or chromosome (as a vector) are regressed on smoking pack-years. The null hypothesis of our proposed test is that all the coefficients relating pack-years to copy numbers are zero, or equivalently, copy numbers at all loci have no association with smoking pack-years, which is equivalent to H 0 : τ=0. The alternative hypothesis would be that copy numbers at some loci have association with smoking pack-years. This variance component test is a powerful test by borrowing information in multiple markers and effectively accounting for correlation among the CNVs in a marker set, and reducing the degrees of freedom of the test.
We used another method to investigate gene selection of CNAs between heavy and light/non-smokers. Both the total probes (T) in which CNAs were detected and the probes locating within genes (G) in which CNAs were detected were calculated for each individual. We proposed a ratio of G vs. T (termed as G/T ratio) to estimate the selection of CNAs with respect to the gene location. Under the null hypothesis that CNAs occur randomly relative to where genes locate, we would expect the null ratio of 40.64%
(104,256/256,554), where 104,256 is the number of probes located within genes on the chip. By comparing the G/T ratios to the null ratio, 40.64%, with two-sided t test, we were able to test whether CNAs occur preferentially away from genes.
To investigate the association of focal copy numbers and smoking pack-years, we analyzed copy number >2 and ≤2 separately. Two outliers (>2. 
